The earnings call presented a mixed picture with both positive growth metrics and ongoing challenges. While revenue and clinical solutions showed strong growth and operational efficiencies improved gross margins, the company continues to face challenges with a negative adjusted EBITDA and lower-than-expected growth in custom products. The overall sentiment reflects cautious optimism with significant progress in some areas, but ongoing challenges in others.

Company Guidance

During Teknova's Second Quarter 2025 Earnings Call, the company provided guidance for the remainder of the year, maintaining a total revenue outlook of $39 million to $42 million, which implies a 7% growth compared to 2024. Revenue for Q2 2025 was reported at $10.3 million, a 7% increase from the same quarter in the previous year. The revenue growth was driven by a 32% increase in Clinical Solutions revenue and low double-digit growth in catalog product sales. Despite macroeconomic challenges affecting early-stage biotech customers, Teknova's gross margin improved significantly to 38.7% from 29.2% in Q2 2024, highlighting gains in manufacturing efficiency. Operating expenses were reduced by $0.5 million due to cost savings, resulting in a net loss of $3.6 million, an improvement from a $5.4 million loss in Q2 2024. The company reiterated its commitment to becoming adjusted EBITDA positive at annualized revenues between $50 million and $55 million, and it expects a free cash outflow of less than $12 million for the full year.

Revenue Growth

Revenue increased by 7% in Q2 2025 compared to Q2 2024, marking the fourth consecutive quarter of year-over-year growth.

Clinical Solutions Revenue Surge

Clinical Solutions revenue increased by 32% from $1.6 million in Q2 2024 to $2.1 million in Q2 2025.

Improved Gross Margin

Gross margin improved to 38.7% in Q2 2025 from 29.2% in Q2 2024, driven by manufacturing efficiency gains and higher revenue.

Cost Reduction and Operational Efficiency

Reduced headcount by about 40% and cut annual operating expenses by approximately $18 million over the past 3 years.

New Facility and Increased Customer Base

Opened a state-of-the-art facility, growing clinical customers from 13 in 2020 to 48 in 2024, supporting over 60 therapies.

Alpha Teknova (TKNO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TKNO Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	-0.09 / -	-0.15	―	―	―
Aug 07, 2025	2025 (Q2)	-0.10 / -0.07	-0.13	46.15% (+0.06)
May 08, 2025	2025 (Q1)	-0.11 / -0.09	-0.2	55.00% (+0.11)
Mar 04, 2025	2024 (Q4)	-0.12 / -0.11	-0.26	57.69% (+0.15)
Nov 07, 2024	2024 (Q3)	-0.11 / -0.15	-0.34	55.88% (+0.19)
Aug 13, 2024	2024 (Q2)	-0.16 / -0.13	-0.25	48.00% (+0.12)
May 13, 2024	2024 (Q1)	-0.24 / -0.20	-0.31	35.48% (+0.11)
Mar 11, 2024	2023 (Q4)	-0.24 / -0.26	-0.47	44.68% (+0.21)
Nov 09, 2023	2023 (Q3)	-0.29 / -0.34	-0.8	57.50% (+0.46)	―
Aug 10, 2023	2023 (Q2)	-0.28 / -0.25	-0.22	-13.64% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TKNO Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$4.34	$4.23	-2.53%
May 08, 2025	$6.37	$6.96	+9.26%
Mar 04, 2025	$6.04	$5.97	-1.16%
Nov 07, 2024	$6.89	$7.16	+3.92%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Alpha Teknova (TKNO) report earnings?

Alpha Teknova (TKNO) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Alpha Teknova (TKNO) earnings time?

Alpha Teknova (TKNO) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TKNO EPS forecast?

TKNO EPS forecast for the fiscal quarter 2025 (Q3) is -0.09.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing